Acute kidney injury (AKI) is a common complication following cardiac surgery performed on cardiopulmonary bypass (CPB) and has important implications for prognosis. The aetiology of cardiac surgery-associated AKI is complex, but renal hypoxia, particularly in the medulla, is thought to play at least some role. There is strong evidence from studies in experimental animals, clinical observations and computational models that medullary ischaemia and hypoxia occur during CPB.
| INTRODUCTION
The development of cardiopulmonary bypass (CPB), to allow cardiothoracic surgeons to operate on a motionless and bloodless field while the patient's cardiovascular system is sustained by a heart-lung machine, was one of the greatest medical breakthroughs of the 20th century. It makes the~2 million coronary artery bypass graft procedures or valve replacement or repair procedures performed annually worldwide possible. 1 However, one of the major risks associated with on-pump cardiac surgery is acute kidney injury (AKI). Globally, the incidence of AKI after cardiac surgery has been estimated at 22.3%, although it does vary according to the diagnostic criteria used. 1 When AKI is severe enough to require renal replacement therapy, as occurs in 1-2% of patients after CPB, mortality exceeds 35%. 2 But even mild AKI after CPB is associated with a more than fourfold greater risk of in-hospital death and greater risk of extended hospitalization. 3 Furthermore, there is now very strong evidence that even short or mild episodes of AKI are independently associated with a greatly increased risk of chronic kidney disease (CKD). 4, 5 Our efforts to prevent AKI associated with cardiac surgery are hampered by three major challenges. The first challenge is that we have little ability to predict which patients will develop AKI after cardiac surgery. Pre-operative risk scoring systems are available, but these only have limited predictive efficacy. 6, 7 Secondly, we lack methods to monitor risk of AKI intra-operatively, prior to development of kidney injury. Urinary and plasma biomarkers have been developed that allow early detection of AKI. 8 However, at best, these can predict AKI on arrival at the intensive care unit (ie, after the operation), 9 and even then their predictive efficacy is rather low. 10, 11 The third challenge is that we have no effective interventions, either during the surgical procedure itself or once AKI has been diagnosed. [12] [13] [14] [15] [16] This suggests that continuous assessment of the kidney during surgery would be advantageous, as this is a promising time for an effective intervention. There are also significant impediments to the development of interventions to prevent or ameliorate AKI associated with cardiac surgery. Patients undergoing cardiac surgery are, for the most part, critically ill. Therefore, the implementation of interventions with questionable efficacy is problematic. Cardiac surgery and CPB are also technically challenging to model in animals. 17 Thus, there are roadblocks in our ability to test new interventions both in preclinical and clinical settings. Another consequence of these impediments is that our understanding of the pathophysiology of cardiac surgery-associated AKI is poor, and so a rational basis for intervention is commensurately limited.
In this article, we review the evidence that renal tissue hypoxia, particularly in the medulla is a likely important driver of AKI, including in the setting of cardiac surgery. We then consider how renal hypoxia could be targeted, both as a way of monitoring risk of AKI and as a therapeutic or management target.
| RENAL OXYGENATION
The oxygenation of all bodily tissues is determined by the balance between oxygen delivery and oxygen consumption. But in the kidney, this apparent simplicity is belied by the complexity of the determinants of oxygen delivery and oxygen consumption, particularly in the renal medulla. 18 In terms of oxygen delivery, we must consider the fact that the renal circulation is arranged in parallel with the non-renal circulations, that the medullary circulation is effectively arranged in parallel with the bulk of the cortical circulation, 19 and that there is likely some level of differential control of perfusion of the inner and outer medulla. So to understand the control of oxygen delivery to the medulla, we must understand the interactions between three sets of nested parallel circulations ( Figure 1 ). Our understanding of the control of local renal tissue oxygen consumption is complicated by the fact that it is so heavily dependent upon tubular sodium reabsorption. 20 Renal oxygen consumption (VO 2 ) can be approximated using the formula:
where VO 2 basal represents an assumed fixed rate of oxygen consumption required for processes independent of sodium reabsorption (~15% of VO 2 total under normal physiological , in turn, is dependent both on the molar quantity of sodium reabsorbed (T Na + ) and the energetic cost of reabsorption of each mole of sodium (b). This formula can be applied both across the whole kidney and at the local level. Given that the effects of vasoactive agents on local medullary tissue oxygenation cannot always be predicted based on their effects on local tissue perfusion and whole-kidney oxygen delivery and consumption, 21 local oxygen consumption probably plays a critical role in determining local tissue oxygen tension. Unfortunately, despite valiant attempts, 22 there are no available methods for quantifying renal oxygen consumption at the local tissue level in vivo. This represents a significant impediment in our understanding of renal oxygenation, as the value of b varies across the various segments of the nephron, 23 is highly dependent on the neurohormonal milieu and particularly the bioavailability of nitric oxide, 24 and likely changes markedly in the diseased 25 or injured 26 kidney. Furthermore, the quantity of sodium reabsorbed within each tubular segments varies with physiological state. 23 Given this uncertainty, we see an important role for computational models to provide a method for systematic data integration, a tool for evaluating "what-if" scenarios, and so a translational pathway between basic research findings and improved clinical practice. The power of computational modelling is that, by repeating the process of model calibration and validation, a model can cumulatively integrate data from all available experiments. This gives researchers a systematic method for taking into account all the available quantitative and qualitative anatomic and physiological data available, past and present, and putting this to work in the service of addressing the research question of interest. By nesting models within models, multiscale computational model can integrate data over a range of length scales, from cells up to tissues and organ systems. This approach is like a lever on experimental data, allowing reassessment and reinterpretation of data, and suggesting new hypotheses as new predictions are made.
One example of this approach is our recently published papers on accounting for oxygen in the rat renal cortex. 27, 28 This model drew on detailed geometrical data that were 
Schematic of the factors that influence renal oxygen delivery. The renal medullary circulation is essentially arranged in parallel with both the extrarenal circulation and the cortical vascular bed. Because the resistance to blood flow in the renal circulation before the point where the juxtamedullary afferent arterioles branch from cortical radial (interlobular) and arcuate arteries is small, the renal circulation can be considered to consist of two resistors in parallel, the outer and mid-cortical vascular bed (R C ) and the juxtamedullary and medullary vascular bed (R M ). The resistance of all other vascular beds can be lumped together as the extrarenal vascular resistance (R ER ). Although the relative levels of extrarenal vascular resistances are not directly relevant to consideration of renal oxygenation, they have a profound impact on the oxygen delivery to other organs such as the brain and splanchnic organs that are also susceptible to damage during cardiopulmonary bypass. Other abbreviations: MAP = mean arterial pressure, P RV = renal venous pressure, RBF = renal blood flow, R R = renal vascular resistance. Note also that there is the potential for redistribution of blood flow between the inner and outer medulla (not shown) gathered with a specific purpose in mind; to assess the importance of renal arterial-to-venous oxygen shunting. However, by integrating these new data in the context of data from another 20+ prior papers on renal anatomy and physiology in the rat, we were able to reveal a critical role for variations in the density of peritubular capillaries in determining renal tissue oxygenation (Figure 2 ). This may at least partly underlie the increased susceptibility of patients with CKD, a condition associated with capillary rarefaction, to development of AKI under conditions like CPB, when there may be mismatched changes in renal oxygen delivery and oxygen consumption. 27 
| EVIDENCE THAT MEDULLARY

HYPOXIA IS A COMMON PATHWAY IN AKI OF MULTIPLE AETIOLOGIES
Here, we will begin to build the case that because renal medulla hypoxia is a common pathway to AKI, this is likely to also be true in AKI associated with CPB. We begin by restating the argument linking AKI to hypoxia.
| The renal medulla is susceptible to hypoxia
Despite the fact that the kidneys receive a quarter of the cardiac output, they are susceptible to hypoxia. 29 Multiple factors render the medulla particularly susceptible to hypoxia, including relatively low blood flow, 18 limitations in oxygen diffusion due to the relatively low capillary density in the kidney 27 and diffusive oxygen shunting in the renal cortex (from arteries to veins) 28, 30 and medulla itself (from descending to long ascending vasa recta). 30, 31 Furthermore, the outer medulla contains the thick ascending limbs of Henle's loop (mTALs), which reabsorb much of the filtered sodium, and so require a large amount of oxygen. Yet the mTALs are located at the periphery of the vascular bundles so have a comparatively meagre oxygen supply. 32 It is not surprising then, that in human Medullary hypoxia is common to animal models of AKI, including radiocontrast-induced nephropathy, ischaemia reperfusion injury, sepsis and rhabdomyolysis. 18 Medullary hypoxia has even been observed in a clinically relevant ovine model of septic AKI in which global renal blood flow (RBF) and oxygen delivery are increased and renal cortical oxygenation is well maintained. 34 It is apparent that medullary hypoxia is not just a consequence of global renal ischaemia, but a specific event common to all forms of AKI where it has been investigated.
| Tissue hypoxia drives pathology
Depletion of cellular ATP initiates signalling cascades leading to inflammation, apoptosis and necrosis. 35 Multiple downstream pathways then exacerbate tissue hypoxia. For example, oxidative stress and loss of Na, K-ATPase polarity and tight junctions between tubular cells reduce the efficiency of oxygen use, which increases oxygen consumption. Cellular protective mechanisms, driven by hypoxia-inducible factors, protect the kidney when hypoxia is mild and/or brief, but fail when hypoxia is severe and/or protracted. 35 Hypoxia may also contribute to the progression from AKI to CKD. 36 For example, capillary rarefaction appears to be an early 37 and persistent 38 event after AKI and is common to all forms of CKD.
39,40
| Medullary hypoxia should reduce glomerular filtration rate
Unfortunately, the mechanistic links between medullary tissue hypoxia and reduced glomerular filtration rate have proved difficult to study. But from a theoretical perspective, we should expect that, as metabolism switches from aerobic to anaerobic, sodium reabsorption in the mTALs should be inhibited. This is predicted to activate the tubuloglomerular feedback (TGF) mechanism, causing afferent arteriolar vasoconstriction, reducing glomerular filtration and further reducing oxygen delivery to the medulla. Hypo-filtration might be exacerbated by oxidative stress and reduced nitric oxide bioavailability and hypoxic damage to tubular and vascular elements in the medulla. 41 Evidence that TGF is linked to renal oxygenation includes the observation of oscillations in glomerular capillary and tubular PO 2 that are dependent on TGF. 42 Nevertheless, the mechanistic links between tissue oxygenation and glomerular filtration remain a major gap in our knowledge of the pathophysiological significance of hypoxia in AKI.
| EVIDENCE OF RENAL ISCHAEMIA AND HYPOXIA DURING AND AFTER CARDIOPULMONARY BYPASS
During CPB, perfusionists monitor mixed venous saturation of haemoglobin with oxygen (SvO 2 ) and maintain it at 70-80%. This level of venous oxygenation is most commonly somewhat greater than that which would be experienced by a resting conscious human (65-75%), so should theoretically be adequate for oxygenation of all organs. However, one must also consider that the local circulations of the various organ systems are in parallel ( Figure 1) . Thus, what is adequate for some organs may not be adequate for others. During CPB, the brain 43 and kidney 44 appear to be particularly susceptible to ischaemia and hypoxia and thus subsequent damage and dysfunction. Multiple factors associated with CPB would be predicted, purely on our understanding of circulatory physiology, to promote renal hypoxia. Haemodilution, a necessary consequence of priming the CPB circuit, blunts autoregulation of RBF. 45 Periods of low pump flow and/or arterial pressure would therefore be expected to result in renal ischaemia. Haemodilution also reduces the oxygen-carrying capacity of blood and therefore the quantity of renal oxygen delivery for any given level of RBF. Haemolysis and associated inflammation and oxidative stress would be expected to lead to renal vasoconstriction, as would activation of the sympathetic and renin-angiotensin systems. Loss of pulsatility of flow might also be expected to promote renal ischaemia.
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Known intra-operative risk factors for AKI after CPB would be expected to lead to renal hypoxia. These include excessive haemodilution 47 or relatively low pump flow leading to low whole body oxygen delivery, 48, 49 and low nadir arterial pressure during CPB. 50 All of these would be expected to reduce renal oxygen delivery. Many pre-operative risk factors are also likely to be associated with reduced oxygen delivery or increased oxygen consumption in the kidney, including chronic obstructive pulmonary disease, CKD, infection and inflammation, and diabetes. 18 Unfortunately, we have virtually no hard evidence regarding the influences of these various factors on RBF during CPB. We are aware of only two studies in which RBF was estimated during CPB in humans, in both cases by measurement of the clearance of para-aminohippurate. Andersson and colleagues found that RBF was highly dependent on both pump flow and arterial pressure during hypothermic (28°C) CPB. 51 They found that RBF was relatively normal at a high pump flow of 2.0-2.2 L/min/m 2 but was reduced by~40% when pump flow was reduced to a level considered adequate for such hypothermic conditions (1.45-
1.65 L/min/m 2 ; note that pump flow is usually calculated as a function of body surface area; ie, equivalent to the "cardiac index"). Critically, they observed a complete absence of autoregulation of RBF. More recently, Lannemyr and colleagues found relatively well-maintained effective RBF during CPB (at 34-35°C), but some redistribution of whole body blood flow away from the kidneys. 52 Nevertheless, because of the effects of haemodilution, while whole body oxygen delivery was well-maintained on CPB, renal oxygen delivery was still reduced by~20%. 52 Even if whole-kidney oxygen delivery is maintained during CPB, there is the potential for altered distribution of blood flow, via microvascular shunting, to induce renal tissue hypoxia by reducing tissue oxygen extraction. Koning and colleagues observed increased heterogeneity of flow in the sublingual circulation of patients during on-pump cardiothoracic surgery, but not during off-pump cardiothoracic surgery. 53 The existence of peri-glomerular shunt pathways in the renal circulation has long been a controversial proposition. 54 Nevertheless, it is noteworthy that Pathi and colleagues observed reduced renal vascular resistance in pigs during CPB (albeit measured by the flawed microsphere method), associated with reductions in glomerular size because of glomerular capillary narrowing. 55 These observations could indicate shunting of RBF away from glomerular capillaries during CPB. A similar mechanism has been proposed as a possible explanation for failure of glomerular filtration in hyperdynamic sepsis. 56 Computational models predict the development of renal medullary hypoxia during CPB. Sgouralis and colleagues simulated hypothermic (28°C) CPB using models of the kidney of the rat. 57, 58 Their findings indicate that the rewarming phase of CPB, prior to weaning from CPB, is a time of greatest risk of medullary hypoxia ( Figure 3 ). Their models predict PO 2 in the vicinity of the mTALH to be <5 mm Hg during rewarming, as a result of the increased metabolic activity and thus oxygen consumption caused by increased tissue temperature. These predictions accord with the clinical observation that rewarming on bypass increases the risk of AKI. 59 Excessive cooling also appears to promote AKI, since arterial perfusion temperature <27°C during CPB was found to be associated with , lower panel). The various phases of cardiac surgery are simulated, including the period prior to induction of anaesthesia (baseline), after induction of anaesthesia but before commencing cardiopulmonary bypass (pre-CPB), during hypothermic (28°C) CPB, during rewarming on CPB (CPB-rewarm) and after weaning from CPB (post-CPB). Three scenarios of are simulated with regard to autoregulation of medullary blood flow, ranging from perfect autoregulation, to partial (50%) autoregulation, to the complete absence of autoregulation. Note that medullary and urinary PO 2 are predicted to fall on CPB, particularly during the rewarming phase. Note also that the discrepancy between the PO 2 of urine in the bladder relative to that in the collecting ducts in part reflects the low urine flow predicted from this computational model. 60 Thus, it may be that the rate of rewarming, rather than the perfusion temperature during hypothermic CPB, is a critical factor in determining risk of AKI. The impact of rewarming regimens on renal haemodynamics and oxygenation has not, to our knowledge, been systematically investigated in experimental animals or man. Renal tissue PO 2 has been directly measured in experimental animals during CPB. In pigs, medullary and urinary hypoxia (PO 2 1-5 mm Hg for both) were observed during CPB. 61 In rats, CPB was associated with transient cortical and medullary hypoxia at a target blood haemoglobin concentration of 10 g/dL, but sustained hypoxia in both regions of the kidney when target haemoglobin was 6.5 g/dL. 62 Thus, evidence from experimental animals strongly supports the proposition that CPB is associated with intra-operative renal hypoxia that is exacerbated by anaemia.
Renal hypoxia also appears to be a hallmark of AKI after CPB. 26 In patients with AKI after CPB, both renal blood flow measured by para-aminohippurate clearance (À40%) and renal oxygen delivery (À62%) were found to be markedly reduced. 63 In contrast, renal oxygen consumption was found to be maintained, despite reduced glomerular filtration rate (GFR) and thus the filtered load of sodium. These observations indicate that the metabolic efficiency of oxygen utilization for sodium reabsorption is reduced in AKI. In pigs, medullary hypoxia was observed 24 hours after CPB. [64] [65] [66] Furthermore, therapies instituted during CPB, that ameliorated post-CPB renal dysfunction, also ameliorated post-CPB medullary hypoxia. These included blockades of endothelin type A receptors, 65 inhibition of phosphodiesterase-5 66 and reversal of intra-operative anaemia. 64 Thus, it appears likely that amelioration of post-CPB renal hypoxia can reduce the risk of renal dysfunction. A method to monitor intrarenal oxygenation intra-operatively may therefore provide a useful tool to manage the risk of AKI in patients during cardiac surgery.
| HOW COULD WE DETECT
INTRA-OPERATIVE RENAL HYPOXIA?
A measure of renal oxygenation during the operation could give a real-time assessment of risk of AKI and potentially justify and enable interventions during surgery (ie, prior to injury). Unfortunately, it is not currently feasible to directly measure the oxygen tension (PO 2 ) of renal tissue during cardiothoracic surgery. However, there have been indirect measurements. Choi and colleagues used near-infrared spectroscopy to assess the regional saturation of intrarenal (and cerebral) haemoglobin with oxygen (rSO 2 ) in 95 adult patients during cardiac surgery with CPB. 67 They found that both renal and cerebral rSO 2 fell at the commencement of CPB. Renal rSO 2 recovered during the initial stages of CPB but then slowly decreased. They also found that patients who developed AKI experienced longer periods during surgery during which saturation of intrarenal haemoglobin with oxygen was below thresholds of 70%, 65%, 60%, 55% and 50%. Furthermore, the odds of post-operative AKI were significantly greater as patients experienced more severe and longer periods of desaturation of renal haemoglobin. Similarly, infants who developed AKI after cardiac surgery on CPB experienced more severe intraoperative desaturation of renal tissue than those who did not develop AKI. 68 Thus, intra-operative monitoring of renal oxygenation could potentially be used to assess the risk of AKI at a time when it might not be too late to intervene to prevent kidney injury. Unfortunately, near-infrared spectroscopy may not be an ideal method for this purpose, as it could not be applied in adult patients whose kidneys were more than 40 mm below the surface of the skin 67 or in paediatric patients older than 12 months or weighing more than 10 kg. 68 We have recently proposed that continuous measurement of urinary PO 2 could be used to estimate renal medullary tissue PO 2 and thus could be used as a "physiological biomarker" of risk of AKI. 69, 70 Our argument was based on the observations that (i) the ascending vasa recta are closely associated with collecting ducts in the medulla so that pelvic urinary PO 2 equilibrates with medullary tissue PO 2 and (ii) the PO 2 of urine in both the renal pelvis and the bladder varies in response to stimuli that would be expected to alter medullary tissue PO 2 . More recently, we developed a computational model of oxygen diffusion across the urothelium of the ureter which predicts good agreement between medullary and bladder urinary PO 2 , provided that urine flow is adequate (Figure 4) . 71 Consistent with this proposition, we found good agreement between medullary tissue PO 2 and bladder urinary PO 2 in sheep during development of sepsis-induced AKI 72 and in rabbits when medullary oxygenation was altered pharmacologically. 71 Kainuma et al 73 One potential solution to avoid CPB-associated renal hypoxia is to avoid CPB altogether. Off-pump cardiac surgery has been found to be associated with a lower risk of AKI than cardiac surgery on CPB. 74, 75 However, in a recent multicentre trial, the investigators could detect no benefit of off-pump surgery in terms of loss of kidney function at 1 year. 74 Thus, significant benefits of off-pump surgery for the kidney have not been demonstrated. This apparent lack of benefit could be due to the common occurrence of haemodynamic instability during off-pump procedures. 76 There is also evidence of poorer outcomes in terms of completeness of revascularization during the surgical procedure and graft patency 1 year after coronary artery bypass graft, 77 and the need for repeat revascularization. 75 
| Anaemia and transfusion
The established relationship between intra-operative anaemia and post-operative AKI (vide supra) provided the impetus for studies of the effects of correction of anaemia by blood transfusion. Available evidence from observational studies indicates that early transfusion to correct anaemia may exacerbate, rather than ameliorate, the risk of AKI. 78 Transfusion of more than two units of packed red blood cells was also found to be associated with increased levels of the urinary biomarkers interleukin-18 and neutrophil gelatinase-associated lipocalin. 79 A potential explanation for this apparent paradox is that stored red blood cells have reduced affinity for oxygen, are less deformable, have shorter lifespans compared with the patient's own red blood cells, and are prone to damage and thus liberation of free haemoglobin. 78, 80 However, the absence of well-designed randomized trials in this field remains a significant impediment to our understanding of the effects of blood transfusion. The results of an ongoing randomized trial comparing a restrictive versus a liberal transfusion strategy may clarify this issue (Transfusion Requirements in Cardiac Surgery III (TRICS-III; National Institutes of Health Clinical Trial Identifier NCT02042898).
| Cooling and rewarming on bypass
Simulations using computational models indicate that cooling on bypass reduces renal oxygen consumption and so protects the renal medulla from hypoxia, but that rewarming on bypass promotes renal medullary hypoxia (Figure 3) . 57, 58 Rewarming on bypass per se, 59 hyperthermic perfusion (arterial outlet temperature >37°C) 81,82 and higher ICU admission temperature 81 has been shown to be associated with increased risk of post-operative AKI. However, neither sustained intra-operative mild hypothermia (34°C vs 37°C) 59 nor sustained moderate hypothermia (28-30°C vs 35.5-36.5°C) 83 was found to be associated with reduced incidence of AKI after coronary artery bypass graft. Furthermore, a recent meta-analysis failed to detect a beneficial effect of therapeutic hypothermia on the incidence of AKI after CPB or in other settings (eg, after cardiac arrest). 84 The lack of apparent benefit of therapeutic hypothermia on post-operative renal function after CPB may reflect both the eventual need for rewarming and the well-established effect of hypothermic perfusion to increase renal vascular resistance. Another approach to prevention of renal hypoxia during CPB could be to optimize haemodynamic conditions during perfusion (ie, pump flow and arterial pressure) to maintain kidney oxygenation. Remarkably, this approach has been little-studied. There are at least three factors that complicate our ability to tailor perfusion conditions to optimize kidney oxygenation. Firstly, we must consider that the kidneys are arranged in parallel with other organs in the systemic circulation (Figure 1) . Consequently, perfusion conditions that are adequate for some organs may not be adequate for the kidney (and vice versa). Secondly, we must consider that the renal medullary circulation is arranged in parallel with the bulk of the renal cortex (excluding the juxtamedullary cortex) 19 and the potential for redistribution of blood flow between the inner and outer medulla ( Figure 1 ). Thus, perfusion conditions that are adequate for the renal cortex may not be adequate for the renal medulla (and vice versa). Thirdly, we must consider that tissue oxygenation is determined by the balance between local oxygen delivery and oxygen consumption. Below, we consider the evidence from clinical studies that perfusion conditions influence post-operative renal function, before considering the experimental evidence that manipulation of perfusion conditions might alter renal perfusion and oxygenation.
| Clinical observations
Intuitively, one would expect that maintenance of both a relatively high pump flow and high MAP during CPB would optimize renal perfusion and oxygenation, and thus mitigate the risk of AKI. There is strong evidence that low pump flow on CPB increases the risk of AKI. 86, 87 However, the impact of arterial pressure during CPB on post-operative renal function remains a matter of controversy. Many observational studies have failed to detect a relationship between MAP on CPB and postoperative renal function. [88] [89] [90] Furthermore, we are unaware of any prospective trials that have demonstrated a clear effect of CPB perfusion pressure on post-operative renal function. For example, Urzua and colleagues failed to detect differences in post-operative outcomes in small samples of patients in whom arterial pressure was maintained above 70 mm Hg by infusion of noradrenaline (n = 7) compared with another group (n = 14) whose arterial pressure during CPB was 10-15 mm Hg lower. 91 Creatinine clearance was greater during CPB, but not post-operatively, in the groups of patients with higher arterial pressure. Similarly, Sirvinskas et al 92 could not detect a relationship between MAP during CPB and post-operative serum creatinine in 122 elderly patients randomized to target levels of MAP of 45.0-59.9 mm Hg, 60.0-69.9 mm Hg or 70-95 mm Hg. On the other hand, it may be that periods of intra-operative hypotension, and/or a failure to match MAP on bypass with pre-operative MAP, increase the risk of AKI, and might not be captured in studies in which MAP is averaged over the total period of CPB. For example, Fischer and colleagues, in a retrospective analysis, also could not detect a relationship between post-operative renal function and average MAP on CPB. 86 However, they did find that patients who developed post-operative acute renal failure (ie, requiring hemofiltration/dialysis) or mild renal impairment experienced longer periods at MAP below 60 mm Hg, and lower mean pump flow on CPB, than those who did not.
Haase and colleagues were unable to reproduce this finding in a larger retrospective study of 920 patients. 90 However, they did identify a trend for intra-operative hypotension to exacerbate the increased risk of AKI associated with intraoperative anaemia. Furthermore, Kanji and colleagues found that the magnitude of the difference between preoperative MAP and MAP on CPB was independently associated with risk of post-operative AKI in a group of 157 high-risk patients. 87 Thus, it remains possible that better management of MAP on bypass, including avoidance of periods of hypotension, particularly in anaemic patients, and better matching of MAP on bypass to the patient's normal resting level of arterial pressure, could mitigate the risk of AKI. Both low haematocrit and low pump flow during CPB are predictors of AKI, but they are also the two major determinants of whole body oxygen delivery, an independent predictor of AKI. 48, 93 This has led to the suggestion that AKI might be avoided in patients with anaemia by increasing pump flow. 94 However, we are not aware of any interventional studies to directly test this hypothesis. Ranucci et al also identified a critical value of whole body oxygen delivery, below which hyperlactaemia is more likely to develop (260 mL/min/m 2 ). We note that these data relate to systemic lactate and whole body oxygen delivery. 94 Specific information on the relationship between renal oxygen delivery and the renal arterio-venous lactate gradient might be useful for optimizing pump flow for management of kidney oxygenation. It is clear from the preceding discussion that optimization of intrarenal oxygenation, and thus potentially the risk of AKI, requires a more evidence-based approach. What, then, can we glean from the available experimental observations?
| Experimental observations
Mackay and colleagues assessed regional perfusion using microspheres in pigs during normothermic CPB. 95 They found that increasing pump flow, and thus perfusion pressure from 45 to 90 mm Hg, increased renal and splanchnic perfusion but not cerebral perfusion. In another study, this group showed that increasing MAP by increasing pump flow was markedly more effective at increasing global RBF than was infusion of phenylephrine to achieve an equivalent MAP at a lower pump flow. 96 Remarkably, they were unable to detect autoregulation of RBF in either study. These experimental observations accord with the only available clinical observations of the effects of altered pump flow on RBF in human patients, showing a virtually linear relationship between RBF and both pump flow and MAP. 51 Thus, although it may be feasible and safe to manipulate MAP pharmacologically without altering pump flow, 97 it seems unlikely that RBF can be improved without some level of increased pump flow. We are not aware of any studies in which the effects of altered MAP, induced by alterations in pump flow and/or vasopressor support, have been systematically investigated with the aim of determining their relative effects on RBF or local renal tissue perfusion and oxygenation. The choice of vasoactive agents and their doses, that could potentially be used to optimize renal tissue oxygenation, must be based on evidence from clinically relevant large-animal models. To this end, Calzavacca and colleagues recently assessed the effects of a range of vasoconstrictor factors on regional kidney perfusion and oxygenation in conscious sheep. 21 Rather surprisingly, they found that the effects of noradrenaline, angiotensin II and arginine vasopressin on renal cortical and medullary oxygenation could not be predicted based on their effects on total RBF, global renal oxygen delivery and renal oxygen consumption, or even regional perfusion as assessed by laser Doppler flowmetry. For example, even though noradrenaline had little effect on total RBF in this healthy ovine model, it greatly reduced both cortical and medullary tissue PO 2 . In contrast, cortical and medullary tissue PO 2 was relatively well-maintained during infusion of arginine vasopressin, even though it markedly reduced global renal blood flow. These observations are consistent with the concept that regional kidney oxygenation is determined by the complex interplay between local tissue perfusion (and thus oxygen delivery to tissue) and local tubular sodium reabsorption (and thus tissue oxygen consumption). 18 They also provide a strong rationale for studies of the effects of vasoactive agents on regional kidney oxygenation and perfusion in a clinically relevant large-animal model of CPB. We are not aware of any published reports of such studies. Thus, we must conclude that we currently have virtually no directly relevant information to inform management of local renal tissue oxygenation through optimization of systemic haemodynamics during CPB.
| Pulsatile versus non-pulsatile flow
Cardiopulmonary bypass most often employs non-pulsatile flow. Available perfusion pump technology can at least partially restore pulsatility towards that achieved by the heart. The relative merits of partial pulsatile versus nonpulsatile flow remain controversial. The increased shearstress and "haemodynamic energy" 98 associated with partial pulsatile flow should theoretically aid tissue perfusion. In humans, partial pulsatile flow on CPB has been demonstrated to improve post-operative perfused vessel density in the sublingual circulation 99 and improve cerebral oxygenation in paediatric patients during CPB. 100 In experimental studies, partial pulsatile flow has also been shown to improve cerebral blood flow during CPB. 101 However, effects on RBF and regional kidney perfusion have been variable. Nakamura et al 102 found that renal tissue perfusion (as assessed by coloured microspheres) improved more during partial pulsatile than non-pulsatile flow in sheep.
Similar observations were made in pigs by Undar et al 101 In contrast, in other experimental studies increased RBF during partial pulsatile CPB has either not been observed 103, 104 or been of marginal significance. 105 It has been argued that the continuing controversy regarding the effectiveness of partial pulsatile flow is a product of the diversity of equipment deployed to achieve pulsatility and its ability to simulate physiological patterns of pulsation. 46 Others have argued that this is not the case, and that the potential benefits of pulsatility are likely blunted by the accompanying greater haemolysis and capillary leak. 104 Clearly, more systematic efforts are required to resolve this long-standing controversy.
| POTENTIAL INTERVENTIONS TO AMELIORATE THE CONSEQUENCES OF RENAL HYPOXIA DURING CARDIOPULMONARY BYPASS
If renal hypoxia cannot be avoided during CPB, perhaps we can find ways to ameliorate its consequences by prophylactic therapies? There has been great recent interest in the potential for remote ischaemic preconditioning (RIPC) to protect the heart and other organs during CPB. In a multicentre clinical trial of 240 patients undergoing on-pump cardiac surgery, Zarbock and colleagues found that the simple manoeuvre of 3 cycles of 5 minutes ischaemia and 5 minutes reperfusion in one upper arm after induction of anaesthesia reduced the absolute risk of AKI by 15%. 106 However, enthusiasm has been dampened somewhat by difficulties in replicating these findings in other studies. Two recent meta-analyses failed to find evidence that RIPC reduces the risk of post-operative AKI. 107, 108 Thus, if RIPC benefits the kidney in cardiac surgery, it might be only under rather specific conditions that remain to be precisely defined. There has also been considerable interest in the potential reno-protective effects of pre-operative activation of hypoxia-inducible factors. 109 However, no therapies have yet been translated into clinical practice. There is also scope to tailor interventions in patients with post-operative AKI to optimize renal oxygenation. 26 Ricksten and colleagues have reported a series of carefully conducted clinical studies in which they assessed renal oxygen delivery and renal oxygen consumption in patients with and without AKI after cardiac surgery. They showed that patients with AKI after cardiac surgery have a deficit in renal oxygen delivery compared to patients without AKI, but that renal oxygen consumption is maintained at relatively normal levels, despite reduced GFR. 63 Thus, AKI after cardiac surgery is associated with increased renal fractional oxygen extraction, indicating a worsening of the renal oxygen supply/demand relationship in these patients. They have also tested the effects of a number of interventions, commonly used to aid resuscitation of the kidney (eg, to increase GFR), on the renal oxygen supply/demand relationship. They found that low-dose vasopressin increased GFR (and thus renal oxygen consumption), but reduced RBF (and thus renal oxygen delivery), so increased the fractional extraction of oxygen by the kidney. 110 In contrast, levosimendan, a drug with both positive inotropic and vasodilator effects, increased both RBF and GFR, so had no detectable effect on the renal fractional extraction of oxygen. 111 Dopamine increased RBF without significantly altering GFR, so reduced renal fractional oxygen extraction. 112 Noradrenaline increased both GFR and RBF, while renal oxygen delivery increased but renal oxygen extraction did not change significantly, so renal fractional oxygen extraction was reduced. 113 They also tested the effects of the diuretics mannitol and furosemide in patients without AKI after CPB. 114 In patients without AKI after cardiac surgery, mannitol increased GFR (and thus renal oxygen consumption) without significantly altering RBF (and thus renal oxygen delivery). Thus, renal fractional oxygen extraction was increased. Combining an infusion of mannitol with furosemide inhibited sodium reabsorption so normalized renal fractional oxygen extraction. In patients with AKI, mannitol increased RBF and tended to increase GFR, so had no detectable effect on fractional renal oxygen extraction. 115 Thus, the effects of mannitol, if they exist, appear to be modulated by the presence of AKI. They also found, in patients without AKI, that crystalloid (Ringer's lactate) but not colloid (Venofundin â ) increased renal fractional oxygen extraction, presumably by increasing GFR. 116 Collectively, the observations described in the paragraph above show that therapies aimed at improving GFR in patients with post-operative AKI should be administered with caution, and with consideration of the likely effects of these treatments on the renal oxygen supply/demand relationship. These findings also provide important guidance for intensivists with regard to the appropriate choice of therapies to optimize global renal oxygenation. However, a note of caution should be added, as their measures of global renal oxygenation do not provide information on the relative oxygenation of the renal cortex and medulla. Noradrenaline infusion, for example, was found not to worsen the global renal oxygen supply/demand relationship in patients with post-operative AKI, 113 healthy conscious sheep, 21 or in conscious sheep with hyperdynamic septic AKI. 72 But in both studies in sheep, in which it was possible to assess local renal tissue oxygenation, noradrenaline was found to induce localized medullary ischaemia and hypoxia. Thus, we really require a method to monitor medullary oxygenation in patients with AKI or at risk of developing AKI. Our recent studies in experimental animals indicate that continuous measurement of urinary PO 2 could provide this capability. 71, 72, 117 8 | CONCLUSIONS AND FUTURE
DIRECTIONS
The aetiology of AKI after CPB is clearly complex. Nevertheless, there is considerable evidence that hypoxia, particularly in the renal medulla, plays some role. We believe at least three approaches are required to advance our understanding of this problem. Firstly, we require clinically relevant models for the study of renal oxygenation during CPB. Recent advances in our ability to monitor regional kidney perfusion and oxygenation in large animals make this feasible. 118 Secondly, we require methods to monitor renal medullary oxygenation in humans during cardiac surgery. Continuous measurement of urinary PO 2 could provide at least a partial solution to this problem. 71, 72 Thirdly,
we require computational models of intrarenal oxygenation applicable to the human condition. Unfortunately, currently available models of kidney oxygenation are based exclusively on the kidney of the rat, 119 but a number of research groups are working towards addressing this deficiency. Combining these approaches could provide a translational pathway to develop ways to detect renal medullary hypoxia during cardiac surgery and develop rational interventions to ameliorate it.
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